Rhythm Biosciences Limited is an Australian medical diagnostics company that specializes in developing and commercializing cutting-edge technology for the early detection of colorectal cancer. The company's flagship product, ColoSTAT, is a groundbreaking blood test that is set to significantly improve the detection and treatment of this deadly disease. Since its incorporation in 2017, Rhythm Biosciences Limited has established itself as a transformative force in the healthcare industry, with its innovative approach earning it a reputation as a company to watch. With its headquarters located in Parkville, Australia, Rhythm Biosciences Limited is poised to make a major impact on the global healthcare scene in the years to come.